The finding that ALDOC plays a tumor‐promoting function in certain melanomas should be taken into consideration when planning therapy trials involving targeting of glycolysis pathways [45, 46, 47] or when ALDOC itself is targeted. This evidence concerns the gene ALDOC and melanoma.